MiR-630 inhibits cells migration and invasion by targeting SOX 4 in triple-negative breast cancer

Objective: To verify whether miR-630 could inhibit Triple-negative Breast Cancer (TNBC) cell line MDAMB-231 cells migration and invasion by targeting SOX4 in TNBC. Methods: Normal breast tissue and breast cancer tissue (44 case of TNBC, 115 case of NTNBC) from patients undergoing breast cancer resection were collected. RT-PCR was used to test the expression of miR-630, miR-21, miR-134, miR-200a, miR-381, miR-1228 and SOX4 mRNA in the tissues; Western blot were used to test the expression of MMP-2, MMP-9, COL1A1, COL1A5 and SOX4 in the tissues. In vitro experiment, after miR-630 mimics was transfected into MDA-MB-231 cells, wound healing assay were employed to test the migratory ability of MDA-MB-231 cells, transwell chambers were used to test the invasion ability of cells, Western blotting were used to investigate the expressions of COL1A1, COL1A5, MMP2, MMP-9 and SOX4. Luciferase assay was used to confirmed whether SOX4-3’-UTR the target gene of miR-630. SOX4 over-expression plasmid was transfected to further confirm miR-630 played its role by down-regulation of SOX4. Results: Compared with normal breast tissue, the expression of miR-630 was decreased in the TNBC tissue (P<0.01); meanwhile COL1A1, COL1A5, MMP-2, MMP-9 and SOX4 was significantly increased (P<0.01); the relative expression of miR-630 level was negatively correlated with SOX4 mRNA (P<0.01). In vitro experiment, compared with the mimic control, the migration and invasion activity of MDA-MB-231 cells was decreased after transfection of miR-630 mimics (P<0.01); meanwhile, miR-630 mimic also decreased the expression of SOX4 in MDA-MB-231 cells (P<0.00). The Luciferase activity of the SOX4-3’-UTR plasmid was significantly suppressed by miR-630 (P<0.00). Over expression of SOX4 could partly abrogated miR-630 mediated inhibition of MDA-MB-231 migration and invasion. Conclusion: In TNBC tissue, the expression of miR-630 decreased; miR-630 inhibits TMDA-MB-231 cells migration and invasion by targeting SOX4-3’-UTR.

[1]  Hiroko Oshima,et al.  MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1 , 2014, Gut.

[2]  S. Meltzer,et al.  MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. , 2012, Gastroenterology.

[3]  Hongming Song,et al.  Up-regulation of miR-506 inhibits cell growth and disrupt the cell cycle by targeting YAP in breast cancer cells. , 2015, International journal of clinical and experimental medicine.

[4]  D. Dhar,et al.  Tetracycline analogues (doxycycline and COL‐3) induce caspase‐dependent and ‐independent apoptosis in human colon cancer cells , 2006, International journal of cancer.

[5]  X. Zhang,et al.  SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2 , 2015, Cell Death and Disease.

[6]  Youyong Lu,et al.  MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells , 2014, Cell Death and Disease.

[7]  D. Cheresh,et al.  Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. , 2015, Trends in cell biology.

[8]  Kui Liu,et al.  miR-21: A gene of dual regulation in breast cancer. , 2016, International journal of oncology.

[9]  Y. Tomari,et al.  The Functions of MicroRNAs: mRNA Decay and Translational Repression. , 2015, Trends in cell biology.

[10]  Dong-Han Chen,et al.  Changes in the expression of MMP2, MMP9, and ColIV in stromal cells in oral squamous tongue cell carcinoma: relationships and prognostic implications , 2012, Journal of experimental & clinical cancer research : CR.

[11]  Y. Joo,et al.  SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma , 2015, BMC Cancer.

[12]  L. O’Driscoll,et al.  miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity , 2015, Oncotarget.

[13]  M. Macías-Silva,et al.  Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. , 2008, Matrix biology : journal of the International Society for Matrix Biology.

[14]  Juan Zhao,et al.  The Roles of MicroRNA-122 Overexpression in Inhibiting Proliferation and Invasion and Stimulating Apoptosis of Human Cholangiocarcinoma Cells , 2015, Scientific Reports.

[15]  Hamza Hanieh,et al.  Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4 , 2015, Molecular Cancer.

[16]  Ying-yu Jin,et al.  MicroRNA-338-3p functions as tumor suppressor in breast cancer by targeting SOX4. , 2015, International journal of oncology.

[17]  G. Tucker-Kellogg,et al.  TIP60-miR-22 axis as a prognostic marker of breast cancer progression , 2015, OncoTarget.

[18]  L. Pfeffer,et al.  miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian Cancer. , 2015, Journal of cancer science & therapy.

[19]  De-ling Liu,et al.  miR-630 targets LMO3 to regulate cell growth and metastasis in lung cancer. , 2015, American journal of translational research.

[20]  Aamir Ahmad,et al.  Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4 , 2015, BMC Cancer.

[21]  Juan Sun,et al.  MiR-211 inhibits cell proliferation and invasion of gastric cancer by down-regulating SOX4. , 2015, International journal of clinical and experimental pathology.

[22]  Guo-Qiang Chen,et al.  MiR-630 suppresses breast cancer progression by targeting metadherin , 2015, Oncotarget.

[23]  Qinghua Zhou,et al.  miR-132 inhibits lung cancer cell migration and invasion by targeting SOX4. , 2015, Journal of thoracic disease.

[24]  De Chen,et al.  Epigenetic Silencing of ITGA2 by MiR-373 Promotes Cell Migration in Breast Cancer , 2015, PloS one.

[25]  Jun Jiang,et al.  Identification of miR-200a as a novel suppressor of connexin 43 in breast cancer cells , 2015, Bioscience reports.

[26]  W. G. Wiles,et al.  SOX4 Is Essential for Prostate Tumorigenesis Initiated by PTEN Ablation. , 2016, Cancer research.

[27]  He Shen,et al.  Sox4 Expression Confers Bladder Cancer Stem Cell Properties and Predicts for Poor Patient Outcome , 2015, International journal of biological sciences.

[28]  L. O’Driscoll,et al.  miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer , 2014, Molecular Cancer.

[29]  Junze Du,et al.  miR-381 suppresses C/EBPα-dependent Cx43 expression in breast cancer cells , 2015, Bioscience reports.